Role of β-adrenergic receptors in insulin resistance: Induction or protection? | ||||
| Zagazig Journal of Pharmaceutical Sciences | ||||
| Article 1, Volume 30, Issue 2, December 2021, Page 1-22 PDF (646.63 K) | ||||
| Document Type: Review Articles | ||||
| DOI: 10.21608/zjps.2021.76693.1021 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Wael Ibrahim1; Islam Ibrahim   1; Amr Mahmoud2; Mona Abdelaziz3
| ||||
| 1Pharmacology and Toxicology Department, Faculty of Pharmacy, Zagazig University | ||||
| 2Pharmacology and Toxicology Department, Faculty of Pharmacy, Zagazig Universiy | ||||
| 3Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University | ||||
| Abstract | ||||
| β Adrenergic receptors, in particular β2 subtype, are key regulators of glucose homeostasis. Previous studies showed that activation of hepatic and adipose tissue β adrenergic receptors mediates insulin desensitizing effects. On the contrary, activation of β adrenergic receptors in the skeletal muscle enhances glucose uptake. However, there is a lot of controversy regarding the metabolic effects of systemic administration of either β adrenergic receptor agonists or antagonists. β2 Agonists have been shown to substantially impair glucose homeostasis while improving it with long-term systemic administration. In the same context, acute and chronic systemic use of certain types of β blockers have been found to enhance insulin action. In this review article, we try to elaborate the underlying mechanisms that regulate glucose metabolism after acute and chronic systemic use of β adrenergic receptor agonists and antagonists in an attempt to answer the question "Do β adrenergic receptors induce or protect against insulin resistance?" | ||||
| Keywords | ||||
| β-Adrenergic receptors; insulin resistance; β-agonists; β-blockers; glucose homeostasis | ||||
|
Statistics Article View: 741 PDF Download: 365 |
||||
